High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.

High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. Diabetes Obes Metab. 2018 03; 20(3):654-659.

View in: PubMed

subject areas

Acute Coronary Syndrome
Cholesterol, LDL
C-Reactive Protein
Diabetes Mellitus, Type 2
Diabetic Angiopathies
Double-Blind Method
Female
Heart Failure
Humans
Hypoglycemic Agents
Male
Middle Aged
Myocardial Infarction
Myocardial Revascularization
Piperidines
Standard of Care
Treatment Outcome
Uracil

authors with profiles

George Bakris